19th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Reproductive Health MedicinesProducts of Interest including new categories: Injectable hormonal contraceptives Depot medroxyprogesterone acetate 104mg/0.65ml (DMPA-SC)1 Attention: Linda Serwaa Deadline for submissions: Electronic documentation to be emailed by Monday  10 March  2025, at 17:00 (Copenhagen time). Sample submissions must reach the UNFPA reception in Copenhagen by Monday, 28 March 2025, at 17:00 (Copenhagen time). contact details Any questions related to the review processes should be addressed to Ms. Linda Serwaa at [email protected].